Rare diseases
Investigational molecules
Locations
Back to Italy820 clinical trials in Florence, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
ItalyStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
ItalyStudy of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression
ItalyStudy on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4
ItalyStudy on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma
ItalyStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
ItalyStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
ItalyStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
ItalyStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
ItalyStudy on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis
ItalyStudy on the Safety and Tolerability of TransCon IL-2 β/γ, Pembrolizumab, and Chemotherapy in Adults with Advanced or Metastatic Solid Tumors
ItalyStudy of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for frontotemporal dementia, multiple sclerosis, and Dravet syndrome. Studies evaluate novel therapeutic approaches including DNL593 for FTD and frexalimab for relapsing MS.
Emphasis on safety assessment and long-term efficacy monitoring.
Comprehensive studies targeting various cancer types including colorectal cancer, breast cancer, and lung cancer. Trials explore combination therapies and novel treatment approaches.
Focus on targeted therapies and personalized treatment approaches.
Investigating treatments for psoriatic arthritis, Sjögren's syndrome, and systemic sclerosis. Research includes evaluation of new biologics and targeted therapies.
Studies aim to improve quality of life and disease management.
Studies examining treatments for COPD and respiratory infections, including evaluation of tezepelumab for moderate to severe COPD and prevention of RSV in infants.
Focus on improving respiratory outcomes and prevention strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
